NCT03313804 2026-03-11Priming Immunotherapy in Advanced Disease With RadiationUniversity of KentuckyPhase 2 Completed76 enrolled 9 charts
NCT04193293 2023-09-21A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck CancerSecuraBioPhase 1/2 Terminated2 enrolled